abstract |
Equation (I) Compounds of or pharmaceutically acceptable salts thereof are provided herein, R 2a , R 2b , R 4a , R 4b , R 6 , R 7 , R 11a , R 11b , R 16 , R 17 , ,. R 3 , R 5 , R 19 , RX and RY are as defined herein. Also provided herein are pharmaceutical compositions comprising a compound of formula (I) and, for example, methods of using the aforementioned compounds in the treatment of CNS-related disorders. For example, compounds designed to act as GABA regulators are provided herein. In some embodiments, such compounds are envisioned to be useful as therapeutic agents for treating CNS-related disorders. |